CreditReports.dk
HomeScreen companies

Disperazol Pharma ApS Financials, key figures and credit report

CVR number: 44265761 Established 2023 Industry: 72 Scientific research and development
Company contact details
Boserupvej 206, 3050 Humlebæk mgivskov@sund.ku.dk tel: 21409867 disperazol.dk
Gross profit -50.0 kDKK FY 2025 -223.4% vs 2024
EBIT -50.0 kDKK FY 2025 -223.4% vs 2024
Net debt -41.0 kDKK FY 2025 +49.1% vs 2024
Quick ratio 2.5 FY 2025 -6.5 vs 2024

Income statement (kDKK)

2024
2025
Fiscal period length1212
Net sales
Gross profit40.50-49.97
EBIT40.50-49.97
Other financial income0.270.45
Other financial expenses-0.21-0.75
Pre-tax profit40.55-50.26
Income taxes-8.938.69
Net earnings31.62-41.57

Assets (kDKK)

2024
2025
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current deferred tax assets8.69
Short term receivables total8.69
Cash and bank deposits80.5541.03
Cash and cash equivalents80.5541.03
Balance sheet total (assets)80.5549.72

Equity and liabilities (kDKK)

2024
2025
Share capital40.0026.48
Retained earnings45.15
Profit of the financial year31.62-41.57
Shareholders equity total71.6230.05
Non-current liabilities total
Short-term deferred tax liabilities8.938.93
Other non-interest bearing current liabilities10.74
Current liabilities total8.9319.67
Balance sheet total (liabilities)80.5549.72
Page generated